News

21 Mar 2022 Hartford HealthCare and Ibex Launch Research Initiative on AI-powered Solution to Improve Breast Cancer Diagnosis

Read more

10 Mar 2022 Dedalus and Ibex announce a strategic partnership to bring the power of artificial intelligence to digital pathology

Read more

24 Nov 2021 Ibex selected by India’s Dr. Lal PathLabs to Deliver AI-powered Cancer Diagnostics

Read more

3 Nov 2021 Ibex Selected by Kantonsspital Baselland to Deliver the First AI-powered Cancer Diagnostics Solution in Switzerland

Read more

18 Oct 2021 Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care

Read more

14 Sep 2021 Ibex Expands United States Operations: Appointing Douglas Clark MD, as Chief Medical Officer, Americas; CEO Relocating to Lead U.S. Headquarters

Read more

24 Aug 2021 Ibex Introduces Galen Gastric, World’s First AI-powered Solution for Gastrointestinal Cancer Diagnostics, at Maccabi Healthcare Services

Read more

11 Aug 2021 Alverno Laboratories Selects Ibex’s AI Solution for Cancer Diagnostics

Read more

21 Jul 2021 Unilabs signs deal with Ibex to deploy AI-powered cancer diagnostics

Read more

7 Jul 2021 Ibex and Sana Kliniken Berlin-Brandenburg Partner to Bring AI-powered Cancer Diagnostics to Germany

Read more

9 Jun 2021 Ibex Granted FDA Breakthrough Device Designation

Read more

26 May 2021 Ibex Obtains CE Mark for AI-Powered Breast Cancer Detection

Read more